Elvira De Leonibus Selected Research

Rett Syndrome (Rett's Disorder)

1/2022

Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elvira De Leonibus Research Topics

Disease

6	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2022 - 05/2013
6	Parkinson Disease (Parkinson's Disease) 12/2021 - 06/2007
6	Mucopolysaccharidoses 01/2021 - 05/2010
4	Inflammation (Inflammations) 01/2022 - 05/2010
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2022 - 07/2014
2	Obesity 01/2023 - 10/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2022 - 01/2020
2	Dementia (Dementias) 01/2021 - 01/2021
2	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 07/2014 - 03/2011
1	Body Weight (Weight, Body) 01/2023
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2022
1	Rett Syndrome (Rett's Disorder) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Synucleinopathies 12/2021
1	Neuroinflammatory Diseases 01/2020
1	Cognitive Dysfunction 01/2020
1	Color Vision Defects (Color Blindness) 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019
1	Dyskinesias (Dyskinesia) 01/2018
1	Muscular Diseases (Myopathy) 11/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 11/2017
1	Multiple Sulfatase Deficiency Disease (Mucosulfatidosis) 05/2011
1	Disease Progression 01/2011
1	Cardiomyopathies (Cardiomyopathy) 01/2011
1	Catalepsy 06/2007

Drug/Important Bio-Agent (IBA)

7	SynucleinsIBA 12/2021 - 01/2018
5	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 02/2009
4	GlycosaminoglycansIBA 01/2022 - 05/2010
4	Lysergic Acid Diethylamide (LSD)IBA 01/2020 - 05/2013
3	Amyloid (Amyloid Fibrils)IBA 11/2022 - 01/2020
3	Levodopa (L Dopa)FDA LinkGeneric 12/2021 - 06/2007
3	EnzymesIBA 07/2014 - 05/2010
2	EndocannabinoidsIBA 01/2023 - 10/2021
2	Retinaldehyde (Retinal)IBA 11/2022 - 01/2020
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022 - 01/2021
2	Haloperidol (Haldol)FDA LinkGeneric 01/2021 - 06/2007
2	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 12/2019 - 05/2013
2	SulfatasesIBA 12/2019 - 05/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 02/2009 - 06/2007
1	Olive OilIBA 01/2023
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	PlasticsIBA 12/2021
1	OrexinsIBA 10/2021
1	SCH 23390IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Prion ProteinsIBA 01/2020
1	alpha-SynucleinIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	CalciumIBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	cannabidivarinIBA 01/2019
1	AntibodiesIBA 01/2019
1	CannabidiolIBA 01/2019
1	DystrophinIBA 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	GlycogenIBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 03/2011
1	deflazacortIBA 01/2011
1	SteroidsIBA 01/2011
1	1-aminocyclopentane-1,3,4-tricarboxylic acidIBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2013
1	Aftercare (After-Treatment) 01/2019